Browse Category

Trump Administration News 30 September 2025 - 5 November 2025

Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

In sum, the Supreme Court appears poised to make a definitive ruling on Trump’s tariff gambit – one that will either vindicate his bold use of emergency power or slam the brakes on it. The stakes are enormous: billions of dollars, the balance of economic power between Congress and the President, and the future course of U.S. trade policy all hang in the balance. As Hofstra law professor James Sample noted, this is “a staggeringly important case” that could reshape the economy and constitutional order for years to come abcnews.go.com. Both Wall Street and Main Street await the outcome, bracing
Trump’s Student Loan Forgiveness Shockwave: 2M Borrowers Freed, Stocks on Edge

Trump’s Student Loan Forgiveness Shockwave: 2M Borrowers Freed, Stocks on Edge

Public Service Loan Forgiveness Overhaul On Oct. 30, 2025 the Dept. of Education finalized a sweeping change to the PSLF program. Citing President Trump’s March 2025 executive order on PSLF, the final rule narrows the definition of a “public service employer” to exclude organizations with a “substantial illegal purpose” ed.gov. That includes entities convicted of aiding illegal immigration, supporting terrorism, providing gender‑affirming care to minors (“prohibited medical procedures”), etc. In announcing the rule, Undersecretary Kent argued that “taxpayer funds should never directly or indirectly subsidize illegal activity” and that PSLF must be refocused on “our Nation’s teachers, first responders, and civil
Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Stock Price & Recent Performance Pfizer’s stock has been rangebound in the low-to-mid $20s for much of 2025. By late September, PFE traded around $23.60 – about 9% below its price a year earlier ts2.tech – as investors grappled with the end of Covid vaccine and treatment revenues. That all changed in early October. In the final trading week of September, Pfizer shares jumped ~15%, rallying from roughly $23.6 (Sept. 25) to about $27.2 by Oct. 1 ts2.tech. This dramatic move was largely driven by two key announcements (see below) and marked one of PFE’s strongest weekly gains in years.
Trump’s Tariff Tsunami: 100% Drug Tax and New Import Levies Rock Global Trade

Trump Seeks a Slice of the Quantum Pie: Stocks Rocket as Govt Eyes IonQ, Rigetti, D-Wave Stakes

Trump Administration’s Quantum Push Citing Wall Street Journal sources, U.S. officials are now treating commercial quantum computing as a strategic sector. Under Secretary Gina Raimondo’s reorganized Chips R&D Office, the Commerce Department is reportedly willing to “go deep” in quantum startups – becoming shareholders in exchange for government R&D grants reuters.com cm.asiae.co.kr. This extends Trump’s “government-as-shareholder” industrial policy in tech; for example, in August the administration agreed to convert nearly $9 billion in CHIPS Act grants into a 10% equity stake in Intel reuters.com cm.asiae.co.kr. The quantum proposals would similarly tie about $10 million of support per company to a U.S.
Tariff Shock and Fed Jitters: Asian Markets Stumble as Rally Meets Reality

Dow Jones Rockets 500 Points as Trump Calms China Tariffs – Market Rally Explained

Market Performance (Oct. 13, 2025) The Dow opened around 45,698 and rallied through the session. By mid-morning it was up ~1.1% (~+517 points at ~45,997) reuters.com. Major tech and financial names were the biggest contributors – Broadcom soared ~9% and topped the index reuters.com; Nvidia, AMD and other chipmakers also gained as AI-related news buoyed sentiment reuters.com. JPMorgan rose after unveiling a $1.5 trillion plan, and Oracle and Estee Lauder jumped on analyst upgrades reuters.com. Defensive sectors lagged (consumer staples down slightly). Fastenal fell on a profit miss reuters.com. Intraday range: The Dow’s intra-day low was near the open (~45,700) and
Student Loan Forgiveness Is Back – 2 Million Borrowers Get Relief as Trump Overhauls Repayment

Student Loan Forgiveness Is Back – 2 Million Borrowers Get Relief as Trump Overhauls Repayment

Forgiveness Finally Arrives for Long-Term Borrowers After months of suspense, thousands of Americans are now seeing decades-old student loans wiped clean. The Education Department’s quiet move to resume IBR loan forgiveness in the first week of October has been met with relief – and tears of joy – from borrowers who’ve made 20 or 25 years of payments. Many received what the community calls the “golden email,” with the message: “You are now eligible to have some or all of your federal student loan(s) discharged because you have reached the necessary number of payments under your Income-Based Repayment Plan.” btimesonline.com
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer (PFE) Stock Soars on Trump’s Drug-Price Pact and $7.3B Weight-Loss Deal

Stock Performance (Sep 2025) On Sept 30, 2025 Pfizer closed around $24.40 reuters.com. Over the past year PFE underperformed the pharma sector (latest 52-week range ~$20.91–30.43 reuters.com). Its trailing P/E is 12.64× reuters.com (ex. special items) and forward P/E ~7.7× reuters.com, compared to ~19× for J&J and ~12× for Merck (see table). Pfizer’s dividend yield (~7.2%) reuters.com is by far the highest in big pharma (JNJ ~2.9%, MRK ~4.1%). The stock rallied on strong earnings in early August s206.q4cdn.com reuters.com and on the Sept 30 Trump pricing news. Q2 2025 Financial Results and Corporate Updates Pfizer reported Q2 2025 revenue
Go toTop